PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 99 positions · Total reported value $4.45B · Top-10 concentration 48.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, PERCEPTIVE ADVISORS LLC disclosed 99 equity positions with a combined reported value of $4.45B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were CERE ($464.92M), FOLD ($398.14M), LIANY ($257.26M). By sector, the heaviest allocations are Health Care 44.8%, Industrials 0.8%. Versus the prior quarter, allocation shifted toward Other (+6.0pp) and away from Health Care (-5.8pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q4 2023 were CRGX ($79.56M), ABBV ($36.88M), CELC ($21.58M).

Of the 12 positions fully exited versus the prior quarter, the largest were ARGX ($74.04M), ROIV ($44.61M), HRMY ($32.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • CRGX CARGO THERAPEUTICS INC · $79.56M
  • ABBV ABBVIE INC · $36.88M
  • CELC CELCUITY INC · $21.58M
  • ISRG INTUITIVE SURGICAL INC · $18.55M
  • ASND ASCENDIS PHARMA A/S · $16.65M
  • ARVN ARVINAS INC · $14.57M
  • AUTL AUTOLUS THERAPEUTICS LTD · $11.79M
  • ITCI INTRA-CELLULAR THERAPIES INC · $7.73M

Fully Exited (vs previous quarter)

  • ARGX ARGENX SE · prev qtr: $74.04M
  • ROIV ROIVANT SCIENCES LTD · prev qtr: $44.61M · history
  • HRMY HARMONY BIOSCIENCES HLDGS IN · prev qtr: $32.65M
  • RLAY RELAY THERAPEUTICS INC COM · prev qtr: $16.34M · history
  • BMEA BIOMEA FUSION INC · prev qtr: $9.86M
  • PRTA PROTHENA CORP PLC · prev qtr: $7.99M
  • OM OUTSET MED INC · prev qtr: $7.20M
  • SLGC SOMALOGIC INC · prev qtr: $3.58M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 44.8%
Materials 0.0%
Other 54.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 10.97M $464.92M 10.44%
10.44%
Add
2 28.06M $398.14M 8.94%
8.94%
Add
3 57.56M $257.26M 5.78%
5.78%
Hold
4 4.54M $252.24M 5.67%
5.67%
Add
5 2.92M $214.73M 4.82%
4.82%
Add
6 4.26M $161.73M 3.63%
3.63%
Hold
7 3.07M $123.75M 2.78%
2.78%
Hold
8 2.15M $99.02M 2.22%
2.22%
Add
9 2.33M $98.08M 2.20%
2.20%
Reduce
10 11.98M $97.39M 2.19%
2.19%
Hold
11 4.02M $95.06M 2.13%
2.13%
Hold
12 1.04M $82.62M 1.85%
1.85%
Add
13 976.65K $80.46M 1.81%
1.81%
Add
14 3.44M $79.56M 1.79%
1.79%
New
15 11.33M $79.54M 1.79%
1.79%
Hold
16 3.87M $76.86M 1.73%
1.73%
Reduce
17 1.73M $73.83M 1.66%
1.66%
Add
18 1.96M $71.44M 1.60%
1.60%
Add
19 1.75M $70.60M 1.59%
1.59%
Hold
20 1.09M $68.36M 1.53%
1.53%
Reduce
21 12.76M $66.85M 1.50%
1.50%
Hold
22 1.02M $59.09M 1.33%
1.33%
Add
23 2.61M $56.10M 1.26%
1.26%
Add
24 850.23K $53.26M 1.20%
1.20%
Add
25 2.14M $53.18M 1.19%
1.19%
Add
26 7.10M $51.97M 1.17%
1.17%
Add
27 1.71M $51.17M 1.15%
1.15%
Add
28 1.83M $51.07M 1.15%
1.15%
Hold
29 1.10M $50.70M 1.14%
1.14%
Add
30 744.06K $46.26M 1.04%
1.04%
Reduce
31 2.00M $45.47M 1.02%
1.02%
Add
32 1.26M $44.67M 1.00%
1.00%
Reduce
33 451.87K $43.57M 0.98%
0.98%
Add
34 3.96M $41.73M 0.94%
0.94%
Add
35 1.73M $37.68M 0.85%
0.85%
Add
36 12.59M $37.66M 0.85%
0.85%
Add
37 238.00K $36.88M 0.83%
0.83%
New
38 3.49M $36.77M 0.83%
0.83%
Hold
39 270.79K $35.68M 0.80%
0.80%
Add
40 151.15K $34.97M 0.79%
0.79%
Add
41 4.00M $30.75M 0.69%
0.69%
Add
42 8.59M $30.16M 0.68%
0.68%
Reduce
43 6.43M $29.08M 0.65%
0.65%
Reduce
44 1.87M $27.51M 0.62%
0.62%
Reduce
45 2.75M $26.44M 0.59%
0.59%
Hold
46 1.30M $26.25M 0.59%
0.59%
Hold
47 818.88K $23.49M 0.53%
0.53%
Reduce
48 967.77K $22.60M 0.51%
0.51%
Add
49 2.43M $22.20M 0.50%
0.50%
Hold
50 1.48M $21.58M 0.48%
0.48%
New

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, PERCEPTIVE ADVISORS LLC reported 99 equity positions worth $4.45B in aggregate; its largest disclosed positions were CERE ($464.92M), FOLD ($398.14M), LIANY ($257.26M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $4.45B of long equity holdings across 99 positions as of 2023-Q4. Top-10 holdings account for 48.7% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →